Novel fibronectin mutations and expansion of the phenotype in spondylometaphyseal dysplasia with "corner fractures".


Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
04 2019
Historique:
received: 09 07 2018
revised: 02 12 2018
accepted: 29 12 2018
pubmed: 2 1 2019
medline: 21 4 2020
entrez: 2 1 2019
Statut: ppublish

Résumé

Heterozygous pathogenic variants in the FN1 gene, encoding fibronectin (FN), have recently been shown to be associated with a skeletal disorder in some individuals affected by spondylometaphyseal dysplasia with "corner fractures" (SMD-CF). The most striking feature characterizing SMD-CF is irregularly shaped metaphyses giving the appearance of "corner fractures". An array of secondary features, including developmental coxa vara, ovoid vertebral bodies and severe scoliosis, may also be present. FN is an important extracellular matrix component for bone and cartilage development. Here we report five patients affected by this subtype of SMD-CF caused by five novel FN1 missense mutations: p.Cys123Tyr, p.Cys169Tyr, p.Cys213Tyr, p.Cys231Trp and p.Cys258Tyr. All individuals shared a substitution of a cysteine residue, disrupting disulfide bonds in the FN type-I assembly domains located in the N-terminal assembly region. The abnormal metaphyseal ossification and "corner fracture" appearances were the most remarkable clinical feature in these patients. In addition, generalized skeletal fragility with low-trauma bilateral femoral fractures was identified in one patient. Interestingly, the distal femoral changes in this patient healed with skeletal maturation. Our report expands the phenotypic and genetic spectrum of the FN1-related SMD-CF and emphasizes the importance of FN in bone formation and possibly also in the maintenance of bone strength.

Identifiants

pubmed: 30599297
pii: S8756-3282(18)30470-8
doi: 10.1016/j.bone.2018.12.020
pii:
doi:

Substances chimiques

Fibronectins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

163-171

Subventions

Organisme : CIHR
ID : 391989
Pays : Canada

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Alice Costantini (A)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, Stockholm 171 76, Sweden.

Helena Valta (H)

Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki 00290, Finland.

Nissan Vida Baratang (NV)

CHU Sainte Justine Research Centre, University of Montreal, Montreal, QC H3T 1C5, Canada.

Patrick Yap (P)

Genetic Health Service New Zealand (Northern Hub), Auckland 1023, New Zealand.

Débora R Bertola (DR)

Centro de Pesquisa sobre o Genoma Humano e Células-Tronco do Instituto de Biociências- Universidade de São Paulo, São Paulo, SP 05508-090, Brazil; Clinical Genetics Unit, Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP 05403-000, Brazil.

Guilherme L Yamamoto (GL)

Centro de Pesquisa sobre o Genoma Humano e Células-Tronco do Instituto de Biociências- Universidade de São Paulo, São Paulo, SP 05508-090, Brazil; Clinical Genetics Unit, Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP 05403-000, Brazil.

Chong A Kim (CA)

Clinical Genetics Unit, Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP 05403-000, Brazil.

Jiani Chen (J)

University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Klaas J Wierenga (KJ)

Mayo Clinic Florida, Jacksonville, FL 32224, USA.

Elizabeth A Fanning (EA)

University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Luis Escobar (L)

Payton Manning Children's Hospital at St. Vincent Health, Indianapolis, IN 46260, USA.

Kirsty McWalter (K)

GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.

Heather McLaughlin (H)

GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.

Rebecca Willaert (R)

GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.

Amber Begtrup (A)

GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.

Jessica J Alm (JJ)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, Stockholm 171 76, Sweden.

Dieter P Reinhardt (DP)

Department of Anatomy and Cell Biology, and Faculty of Dentistry, McGill University, Montreal, QC H3A 0C7, Canada.

Outi Mäkitie (O)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, Stockholm 171 76, Sweden; Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki 00290, Finland; Department of Clinical Genetics, Karolinska University Hospital, Stockholm 171 76, Sweden; Folkhälsan Institute of Genetics, University of Helsinki, Helsinki 00290, Finland. Electronic address: outi.makitie@helsinki.fi.

Philippe M Campeau (PM)

CHU Sainte Justine Research Centre and Department of Pediatrics, University of Montreal, Montreal, QC H3T 1C5, Canada. Electronic address: p.campeau@umontreal.ca.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH